Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BPMC | Blueprint Medicines Corp | Director | $17.6 M | -$10.1 M | -36.5% | Jun 12, 2024 |
AGLE | Spyre Therapeutics, Inc. | Director | $19.3 K | May 14, 2024 | ||
KYMR | Kymera Therapeutics, Inc. | Director | $0 | -$496 K | -100% | Jun 18, 2024 |
DNTH | Dianthus Therapeutics, Inc. /DE/ | Director | Jun 28, 2022 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|